Is Aravive, Inc. (ARAV) a Buy, Sell, or Hold?
NASDAQ : ARAV
Aravive, Inc. — Insider Trades
$0.0401 USD
-$0.01 (-13.39%)
- Volume
- 4.04M
- Average Volume
- 2.16M
- Market Capitalization
- $2.95M
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- $0.25
- Year High
- $2.46
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.73
Insider Activity Summary (Last 12 Months)
Insiders Buying
34
Insiders Selling
0
Amount of Insider Selling
-$
ARAV Insider Buying/Selling by Quarter
ARAV Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Petrini Maria Carolina | officer: Chief Commercial Officer | 2023-04-10 | A-Award | 1.86 | 2023-04-11 |
| Petrini Maria Carolina | officer | 2023-04-10 | 0 | 2023-04-11 | |
| McIntyre Gail Frances | director, officer: CEO and President | 2023-02-01 | A-Award | 1.67 | 2023-02-02 |
| Geller Robert B. | officer: Chief Medical Officer | 2023-02-01 | A-Award | 1.67 | 2023-02-02 |
| HOWARD RUDY | officer: Chief Financial Officer | 2023-02-01 | A-Award | 1.67 | 2023-02-02 |
| Dove Leonard Scott | officer: Chief Operating Officer | 2023-02-01 | A-Award | 1.67 | 2023-02-02 |
| Ho Peter Tai-Ching | director | 2022-10-24 | A-Award | 0.9199 | 2022-10-27 |
| Zhang Eric | director | 2022-10-24 | A-Award | 0.7949 | 2022-10-27 |
| Zhang Eric | director | 2022-10-24 | A-Award | 0.7949 | 2022-10-27 |
| Giaccia Amato | director | 2022-10-24 | A-Award | 0.9199 | 2022-10-26 |
| Giaccia Amato | director | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| Zhang Eric | director | 2022-10-24 | A-Award | 0.9199 | 2022-10-26 |
| Zhang Eric | director | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| Zhang Eric | director | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| HOWARD RUDY | officer: Chief Financial Officer | 2022-10-24 | A-Award | 0.9199 | 2022-10-26 |
| HOWARD RUDY | officer: Chief Financial Officer | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| McIntyre Gail Frances | officer: CEO and President | 2022-10-24 | A-Award | 0.9199 | 2022-10-26 |
| McIntyre Gail Frances | officer: CEO and President | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| McIntyre Gail Frances | officer: CEO and President | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| Ho Peter Tai-Ching | director | 2022-10-24 | A-Award | 0.7949 | 2022-10-26 |
| Ho Peter Tai-Ching | director | 2022-10-24 | A-Award | 0.7949 | 2022-10-26 |
| ESHELMAN FREDRIC N | officer: Executive Chairman | 2022-10-24 | A-Award | 0.9199 | 2022-10-26 |
| ESHELMAN FREDRIC N | officer: Executive Chairman | 2022-10-24 | A-Award | 0 | 2022-10-26 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman | 2022-10-24 | A-Award | 0.7949 | 2022-10-26 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman | 2022-10-24 | A-Award | 0.7949 | 2022-10-26 |
| Kirk Sigurd | director | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| ROGERS MICHAEL W | director | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| Zhang Eric | director | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| Giaccia Amato | director | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| Ho Peter Tai-Ching | director | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| Hohneker John | director | 2022-09-23 | A-Award | 0.9152 | 2022-09-26 |
| Geller Robert B. | officer: Chief Medical Officer | 2022-07-01 | A-Award | 0 | 2022-07-05 |
| Geller Robert B. | officer | 2022-07-01 | 0 | 2022-07-05 | |
| HOWARD RUDY | officer: Chief Financial Officer | 2022-06-03 | A-Award | 0 | 2022-06-03 |
| HOWARD RUDY | officer | 2022-06-03 | 0 | 2022-06-03 | |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman of Board | 2022-04-01 | M-Exempt | 0.0001 | 2022-04-04 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman of Board | 2022-04-01 | M-Exempt | 0.0001 | 2022-04-04 |
| Eshelman Ventures, LLC | director: | 2022-04-01 | M-Exempt | 0 | 2022-04-04 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman of Board | 2022-03-29 | A-Award | 2.325 | 2022-03-31 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman of Board | 2022-03-29 | A-Award | 2.2 | 2022-03-31 |
| Eshelman Ventures, LLC | director: | 2022-03-29 | A-Award | 2.2 | 2022-03-31 |
| Dove Leonard Scott | officer: Chief Operating Officer | 2022-03-21 | A-Award | 0 | 2022-03-22 |
| Dove Leonard Scott | officer | 2022-03-21 | 0 | 2022-03-22 | |
| McIntyre Gail Frances | director, officer: CEO and President | 2022-01-24 | A-Award | 2.18 | 2022-01-25 |
| Shah Vinay | officer: Chief Financial Officer | 2022-01-24 | A-Award | 2.18 | 2022-01-25 |
| Rangwala Reshma | officer: Chief Medical Officer | 2022-01-24 | A-Award | 2.18 | 2022-01-25 |
| ESHELMAN FREDRIC N | director, 10 percent owner, officer: Executive Chairman of Board | 2022-01-03 | A-Award | 0.0001 | 2022-01-05 |
| Giaccia Amato | director | 2021-12-03 | G-Gift | 0 | 2021-12-23 |
| Giaccia Amato | director | 2021-11-30 | M-Exempt | 0.24 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | S-Sale | 3.22 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | M-Exempt | 0.24 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | S-Sale | 3.22 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | S-Sale | 3.22 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | M-Exempt | 0.06 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | M-Exempt | 0.24 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | M-Exempt | 0.24 | 2021-12-02 |
| Giaccia Amato | director | 2021-11-30 | M-Exempt | 0.06 | 2021-12-02 |
| ESHELMAN FREDRIC N | director, 10 percent owner: | 2021-09-10 | A-Award | 3.97 | 2021-09-13 |
| Giaccia Amato | director | 2021-09-10 | A-Award | 3.97 | 2021-09-13 |
| Zhang Eric | director | 2021-09-10 | A-Award | 3.97 | 2021-09-13 |
| Hohneker John | director | 2021-09-10 | A-Award | 3.97 | 2021-09-13 |
| ROGERS MICHAEL W | director | 2021-09-10 | A-Award | 3.97 | 2021-09-13 |
| Ho Peter Tai-Ching | director | 2021-09-10 | A-Award | 3.97 | 2021-09-13 |
| Kirk Sigurd | director | 2021-09-10 | A-Award | 0 | 2021-09-13 |
| Ho Peter Tai-Ching | director | 2021-07-01 | A-Award | 5.8 | 2021-07-02 |
| Ho Peter Tai-Ching | director | 2021-07-01 | A-Award | 5.8 | 2021-07-02 |
| Kirk Sigurd | director | 2021-07-01 | A-Award | 5.8 | 2021-07-02 |
| Kirk Sigurd | director | 2021-07-01 | A-Award | 5.8 | 2021-07-02 |
| Hohneker John | director | 2021-07-01 | A-Award | 5.8 | 2021-07-02 |
| Hohneker John | director | 2021-07-01 | A-Award | 5.8 | 2021-07-02 |
| McIntyre Gail Frances | director, officer: CEO and President | 2021-06-29 | P-Purchase | 5.345 | 2021-06-29 |
| Shah Vinay | officer: Chief Financial Officer | 2021-06-29 | P-Purchase | 5.31 | 2021-06-29 |
| Kirk Sigurd | director: | 2021-05-12 | 0 | 2021-05-21 | |
| Ho Peter Tai-Ching | director | 2021-05-12 | 0 | 2021-05-21 | |
| Hohneker John | director: | 2021-05-12 | 0 | 2021-05-21 | |
| Giaccia Amato | director | 2021-03-19 | M-Exempt | 0.06 | 2021-03-22 |
| Giaccia Amato | director | 2021-03-19 | M-Exempt | 0.06 | 2021-03-22 |
| Giaccia Amato | director | 2021-03-19 | G-Gift | 0 | 2021-03-22 |
| Giaccia Amato | director | 2021-03-19 | M-Exempt | 0.06 | 2021-03-22 |
| ESHELMAN FREDRIC N | director, 10 percent owner: | 2021-02-12 | A-Award | 7.29 | 2021-02-17 |
| Rangwala Reshma | officer: Chief Medical Officer | 2021-01-25 | A-Award | 5.95 | 2021-01-26 |
| McIntyre Gail Frances | director, officer: CEO and President | 2021-01-25 | A-Award | 5.95 | 2021-01-26 |
| Shah Vinay | officer: Chief Financial Officer | 2021-01-25 | A-Award | 5.95 | 2021-01-26 |
| Shah Vinay | officer: Chief Financial Officer | 2020-12-04 | P-Purchase | 5.76 | 2020-12-07 |
| McIntyre Gail Frances | director, officer: CEO and President | 2020-12-04 | P-Purchase | 5.77 | 2020-12-07 |
| Rangwala Reshma | officer: Chief Medical Officer | 2020-09-28 | A-Award | 4.95 | 2020-09-29 |
| Rangwala Reshma | officer | 2020-09-28 | 0 | 2020-09-29 | |
| ROGERS MICHAEL W | director | 2020-09-15 | A-Award | 5.99 | 2020-09-17 |
| ROGERS MICHAEL W | director | 2020-09-15 | A-Award | 5.99 | 2020-09-17 |
| ROGERS MICHAEL W | director: | 2020-09-15 | 0 | 2020-09-17 | |
| ESHELMAN FREDRIC N | director | 2020-09-14 | A-Award | 5.63 | 2020-09-15 |
| Tabibiazar Raymond | director | 2020-09-14 | A-Award | 5.63 | 2020-09-15 |
| Giaccia Amato | director | 2020-09-14 | A-Award | 5.63 | 2020-09-15 |
| Zhang Eric | director | 2020-09-14 | A-Award | 5.63 | 2020-09-15 |
| ESHELMAN FREDRIC N | director | 2020-06-01 | A-Award | 12.72 | 2020-06-03 |
| ESHELMAN FREDRIC N | director | 2020-06-01 | A-Award | 12.72 | 2020-06-03 |
| ESHELMAN FREDRIC N | director | 2020-04-08 | 0 | 2020-04-10 | |
| McIntyre Gail Frances | director, officer: CEO and President | 2020-04-08 | A-Award | 6.16 | 2020-04-09 |
| Hemrajani Rekha | 2020-04-08 | D-Return | 0 | 2020-04-09 |